{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:02:21Z","timestamp":1784869341485,"version":"3.55.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a member of the serine\/threonine kinase family, is an important oncogene in glioblastoma. IKBKE is involved in the progression of multiple tumours in glioblastoma (GBM), including tumour invasion, migration, and proliferation. Here, we report an IKBKE\u2013angiomotin-like protein 2 (Amotl2)\u2013yes-associated protein 1 (YAP1) axis in which IKBKE inhibits the protein expression of Amotl2, while Amotl2 regulates the nuclear transport of the YAP1 protein, which has been implicated in brain tumour development and progression. Data analysis of multiple IKBKE mRNA databases of glioma and immunohistochemical analysis of a tissue chip indicated that higher IKBKE expression was associated with higher malignancy and shorter survival in glioma patients. IKBKE downregulation significantly inhibited GBM cell proliferation and restrained tumour growth in a GBM mouse model. Moreover, IKBKE phosphorylates Amotl2, promoting Amotl2 ubiquitination and degradation, leading to YAP1 entry into the nucleus and the activation of downstream genes. In summary, our results are the first to show that IKBKE phosphorylates Amotl2 and that GBM cell proliferation is regulated by the IKBKE\u2191\u2013Amotl2\u2193\u2013YAP1\u2191 axis.<\/jats:p>","DOI":"10.3389\/fonc.2026.1823895","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:30Z","timestamp":1784867070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth"],"prefix":"10.3389","volume":"16","author":[{"given":"Gaochao","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Henan Provincial People,s Hospital; Zhengzhou University People,s Hospital; Cerebrovascular Disease Hospital","place":["Zhengzhou, Henan, China"]},{"name":"Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Yantai Yuhuangding Hospital","place":["Yantai, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Hong","sequence":"additional","affiliation":[{"name":"Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Lu","sequence":"additional","affiliation":[{"name":"Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Chen","sequence":"additional","affiliation":[{"name":"Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Henan Provincial People,s Hospital; Zhengzhou University People,s Hospital; Cerebrovascular Disease Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Henan Provincial People,s Hospital; Zhengzhou University People,s Hospital; Cerebrovascular Disease Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Henan Provincial People,s Hospital; Zhengzhou University People,s Hospital; Cerebrovascular Disease Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other Malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA J Am Med Assoc"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.73.0119","article-title":"Adult glioblastoma","volume":"35","author":"Alexander","year":"2017","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not030","article-title":"In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles","volume":"15","author":"Chu","year":"2013","journal-title":"Neuro-Oncology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30505","article-title":"Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor","volume":"140","author":"Ciaglia","year":"2017","journal-title":"Int J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-16-2598","article-title":"Tumor purity as an underlying key factor in glioma","volume":"23","author":"Zhang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-022-01513-z","article-title":"Glioma targeted therapy: insight into future of molecular approaches","volume":"21","author":"Yang","year":"2022","journal-title":"Mol Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-\u03b5 improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2678","article-title":"Advances in IKBKE as a potential target for cancer therapy","volume":"9","author":"Yin","year":"2019","journal-title":"Cancer Med-Us"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00940-1","article-title":"IKBKE phosphorylates and stabilizes Snail to promote breast cancer invasion and metastasis","volume":"29","author":"Xie","year":"2022","journal-title":"Cell Death Differ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.42352","article-title":"Inhibitor of nuclear factor kappa-B kinase epsilon contributes to neuropsychiatric manifestations in lupus-prone mice through microglial activation","volume":"75","author":"Karino","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1517855","article-title":"Activated kinase screening identifies the IKBKE oncogene as a positive regulator of autophagy","volume":"15","author":"Leonardi","year":"2019","journal-title":"Autophagy"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.396","article-title":"Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2012-3255","article-title":"IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer","volume":"32","author":"Guo","year":"2013","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2005.08.006","article-title":"IKK-i signals through IRF3 and NF\u03baB to mediate the production of inflammatory cytokines","volume":"18","author":"Sankar","year":"2006","journal-title":"Cell Signal"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/ni921","article-title":"IKK\u03f5 and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02726-2","article-title":"Silencing IKBKE inhibits the migration and invasion of glioblastoma by promoting Snail1 degradation","volume":"24","author":"Liu","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c05399","article-title":"Amlexanox enhances temozolomide-induced antitumor effects in human glioblastoma cells by inhibiting IKBKE and the Akt-mTOR signaling pathway","volume":"6","author":"Xiong","year":"2021","journal-title":"ACS Omega"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02251-3","article-title":"IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma","volume":"22","author":"Guo","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.130","article-title":"IKBKE, a prognostic factor preferentially expressed in mesenchymal glioblastoma, modulates tumoral immunosuppression through the STAT3\/PD\u2010L1 pathway","volume":"10","author":"Yi","year":"2020","journal-title":"Clin Transl Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17738","article-title":"IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human Malignant glioma via the Hippo pathway","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/path.2815","article-title":"IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-kappaB","volume":"223","author":"Guan","year":"2011","journal-title":"J Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2012.1452","article-title":"Silencing of IKK\u03f5 using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo","volume":"41","author":"Huang","year":"2012","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2013.05.014","article-title":"Polarity-dependent distribution of Angiomotin localizes Hippo signaling in preimplantation embryos","volume":"23","author":"Hirate","year":"2013","journal-title":"Curr Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.19603","article-title":"Angiomotin family members: oncogenes or tumor suppressors","volume":"13","author":"Lv","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7554\/elife.08201","article-title":"Amotl2a interacts with the Hippo effector Yap1 and the Wnt\/\u03b2-catenin effector Lef1 to control tissue size in zebrafish","volume":"4","author":"Agarwala","year":"2015","journal-title":"Elife"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5557","article-title":"AmotL2 disrupts apical\u2013basal cell polarity and promotes tumour invasion","volume":"5","author":"Mojallal","year":"2014","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004573","article-title":"Angiomotin'g YAP into the nucleus for cell proliferation and cancer development","volume":"6","author":"Hong","year":"2013","journal-title":"Sci Signal"},{"key":"B28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1101\/gad.2000111","article-title":"Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein","volume":"25","author":"Zhao","year":"2011","journal-title":"Gene Dev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.15252\/embr.201540809","article-title":"Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition","volume":"17","author":"Kim","year":"2016","journal-title":"EMBO Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.785463","article-title":"HOTAIR up-regulation activates NF-\u03baB to induce immunoescape in gliomas","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41419-017-0253-7","article-title":"The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.canlet.2018.11.034","article-title":"PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma","volume":"443","author":"Zhang","year":"2019","journal-title":"Cancer Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1038\/s41467-018-07022-2","article-title":"Reciprocal inhibition of YAP\/TAZ and NF-\u03baB regulates osteoarthritic cartilage degradation","volume":"9","author":"Deng","year":"2018","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1805633115","article-title":"Photoaffinity-engineered protein scaffold for systematically exploring native phosphotyrosine signaling complexes in tumor samples","volume":"115","author":"Chu","year":"2018","journal-title":"P Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7150\/thno.42795","article-title":"The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell Malignancy","volume":"10","author":"Guo","year":"2020","journal-title":"Theranostics"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m115.656587","article-title":"Phosphorylation of the Hippo pathway component AMOTL2 by the mTORC2 kinase promotes YAP signaling, resulting in enhanced glioblastoma growth and invasiveness","volume":"290","author":"Artinian","year":"2015","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"7548","DOI":"10.1038\/s41598-017-07968-1","article-title":"AmotL2 integrates polarity and junctional cues to modulate cell shape","volume":"7","author":"Hultin","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1038\/ncomms4743","article-title":"AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion","volume":"5","author":"Hultin","year":"2014","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.m111.296806","article-title":"Angiomotin-like2 gene (amotl2) is required for migration and proliferation of endothelial cells during angiogenesis","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)80445-1","article-title":"IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex","volume":"5","author":"Peters","year":"2000","journal-title":"Mol Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.8.1357","article-title":"IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases","volume":"11","author":"Shimada","year":"1999","journal-title":"Int Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.04.031","article-title":"Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKK\u03b5 promotes cell transformation","volume":"34","author":"Hutti","year":"2009","journal-title":"Mol Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016132108","article-title":"IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation","volume":"108","author":"Xie","year":"2011","journal-title":"P Natl Acad Sci U S A"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1823895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:24:31Z","timestamp":1784867071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1823895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":43,"alternative-id":["10.3389\/fonc.2026.1823895"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1823895","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"article-number":"1823895"}}